Hyperion DeFi, Inc.

Hyperion DeFi, Inc.

HYPD - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$32.66M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Hyperion DeFi, Inc.Hyperion DeFi, Inc.-0.7-1%--
$8.92

Target Price by Analysts

328.7% upsideHyperion DeFi Target Price DetailsTarget Price
$-2.97

Current Fair Value

243% downside

Overvalued by 243% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$32.66 Million
Enterprise Value$-5,250,559,959.00
Earnings per Share$-9.4
Beta2.74
Outstanding Shares15,701,943

Return

Return on Equity1.03%ROE
Return on Assets1.00%
Return on Invested Capital1.51%

Valuation & Multiples

P/E Ratio-0.69P/E Ratio
PEG0PEG
Price to Sales0.04Price to Sales
Price to Book Ratio0.0Price to Book Ratio
Enterprise Value to Revenue-6.44
Enterprise Value to EBIT-2.44
Enterprise Value to Net Income-4
Total Debt to Enterprise-0.26
Debt to Equity0.01Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 12, 2026
EPS
$1.23
Est. $2.31
Revenue
$810,415
Est. $2.00 M

Next Earnings Call

Expected Date
March 25, 2027
EPS Estimate
$0.47
Consensus analyst estimate
Revenue Estimate
$4.23 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %20.83%▲ 3.04%
Total Invested$10.80M▲ 36.30%
Investors Holding32▼ 1.00%

About Eyenovia Inc

33 employees
CEO: Hyunsu Jung

Eyenovia, Inc. is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis.

Hyperion DeFi Insider Information FAQ

Stockcircle shows 2 open-market insider purchases for Hyperion DeFi in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.

Questions & Answers